Close

Send to a Friend Font Size: Increase Decrease

Highbridge Capital

Highbridge Capital's Portfolio

Ticker	# of Shares	Price	Value
	75,000,000	$1,141.93	$85,644,750,000
	72,000,000	$1,141.93	$82,218,960,000
	65,000,000	$1,141.93	$74,225,450,000
	65,000,000	$1,141.93	$74,225,450,000
	63,500,000	$1,141.93	$72,512,555,000
	56,358,000	$1,141.93	$64,356,890,940
	54,470,000	$1,141.93	$62,200,927,100
	54,248,000	$1,141.93	$61,947,418,640
	48,500,000	$1,141.93	$55,383,605,000
	47,386,000	$1,141.93	$54,111,494,980
View Additional Portfolio Information »

Highbridge Capital

Login to help us fill in information about this entity.

Pernix Therapeutics (PTX) Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management, Files for Chapter 11 Protection Feb 19, 2019 09:16AM

Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management Feb 19, 2019 09:15AM

Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management Feb 19, 2019 09:15AM

Pernix Therapeutics Announces Successful Closing of Transaction Regarding Worldwide Rights to Contrave® for Weight Loss Jul 30, 2018 08:00AM

Pernix Therapeutics Announces Successful Closing of Transaction Regarding Worldwide Rights to Contrave® for Weight Loss Jul 30, 2018 08:00AM

Jul 31, 2017 05:02PM Form SC 13G PERNIX THERAPEUTICS HOLD Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC